Willis-Knighton Cancer Center’s Department of Radiation Oncology is being represented this week at the annual world conference of the American Society of Radiation Oncology (ASTRO). ASTRO’s annual meeting is touted as the premier radiation oncology scientific event in the world and draws more than 11,000 to hear presentations.
Director of Radiation Oncology at the Willis-Knighton Cancer Center, Dr. Lane R. Rosen joins current and former medical students who are sharing research at the event. Joining Rosen in presenting are Dr. Ben Fischer-Valuck and medical students Addison Willett and Mary Dean.
Thought leaders in the field gather regularly to share and learn from the brightest minds in the field. Lung, skin and cervical cancer are among the topics being covered by the Willis-Knighton-connected doctors and students.
The Willis-Knighton Cancer Center, part of Willis-Knighton Health System in Shreveport, La., has been a leading-edge center for radiation oncology, including Intensity Modulated Radiation Therapy (IMRT) and was among the first cancer centers in the world to offer TomoTherapy. Physicians and physicists from leading cancer centers in the U.S. and worldwide have visited Shreveport to learn from experts at the Willis-Knighton Cancer Center. Continuing its tradition of innovation, the center is adding proton therapy to its arsenal of cancer-fighting techniques. Delivery of the ProteusONE®, designed and manufactured by in Belgium by Ion Beam Applications, the world leader in proton therapy, began in July. Willis-Knighton plans the center to open in early 2014 and be fully operational later in the year.